Orchestration of secretory protein folding by ER chaperones  by Gidalevitz, Tali et al.
Biochimica et Biophysica Acta 1833 (2013) 2410–2424
Contents lists available at SciVerse ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r .com/ locate /bbamcrReview
Orchestration of secretory protein folding by ER chaperones☆,☆☆
Tali Gidalevitz a, Fred Stevens b, Yair Argon c,d,⁎
a Department of Biology, Drexel University, 418 Papadakis Integrated Science Bldg., 3245 Chestnut Street, Philadelphia, PA 19104, USA
b Argonne National Laboratory, Argonne, IL 60439, USA
c Division of Cell Pathology, Department of Pathology and Lab Medicine, The Children's Hospital of Philadelphia, 3615 Civic Center Blvd., Philadelphia, PA 19104, USA
d The University of Pennsylvania, Philadelphia, PA 19104, USA☆ This article is part of a Special Issue entitled: Functi
endoplasmic reticulum.
☆☆ We dedicate this paper to the memory of our colle
passed away suddenly. His brilliant insights into prote
thinking about chaperones and have impacted our wor
sorely missed.
⁎ Corresponding author at: Division of Cell Patholo
and Lab Medicine, The Children's Hospital of Philadel
Philadelphia, PA 19104, USA. Tel.: +1 267 426 5131; f
E-mail address: yargon@mail.med.upenn.edu (Y. A
0167-4889/$ – see front matter © 2013 Elsevier B.V. Al
http://dx.doi.org/10.1016/j.bbamcr.2013.03.007a b s t r a c ta r t i c l e i n f oArticle history:
Received 11 December 2012
Received in revised form 27 February 2013
Accepted 1 March 2013
Available online 15 March 2013
Keywords:
Endoplasmic reticulum
Chaperones
Protein folding
SecretomeThe endoplasmic reticulum is a major compartment of protein biogenesis in the cell, dedicated to production of
secretory, membrane and organelle proteins. The secretome has distinct structural and post-translational
characteristics, since folding in the ER occurs in an environment that is distinct in terms of its ionic composition,
dynamics and requirements for quality control. The folding machinery in the ER therefore includes chaperones
and folding enzymes that introduce, monitor and react to disulﬁde bonds, glycans, and ﬂuctuations of luminal
calcium. We describe the major chaperone networks in the lumen and discuss how they have distinct modes
of operation that enable cells to accomplish highly efﬁcient production of the secretome. This article is part of
a Special Issue entitled: Functional and structural diversity of endoplasmic reticulum.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
The great majority of extracellular, surface-expressed, secretory and
endosomal eukaryotic proteins, totaling over 18,000 in the secreted
protein database [1], fold and assemble in the endoplasmic reticulum
(ER). Thus, in addition to being a major site for lipid biosynthesis and
amajor calcium store (reviewed elsewhere in this issue), folding of pro-
teins is one of themain functions of the ER. Precise control over the rate
of production and the “quality” of their structure is essential for every
aspect of metazoan organisms, frommorphogenesis during the embry-
onic development, to the complex endocrine regulation in aging. In this
review, we will discuss how the complex processes of protein folding
and assembly are supported by the specialized conditions in the ER.2. Restricting an inﬁnite folding landscape
Anﬁnsen's axiom that the necessary information for folding of a
protein is encoded within the amino acid sequence itself was derived
from spontaneous refolding of pure protein samples after denatur-
ation [2,3]. Though undoubtedly true, this principle does not sufﬁceonal and structural diversity of
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l rights reserved.to explain protein folding in the cell, because the theoretical “folding
space” is too vast [4], and therefore needs to be restricted to be com-
patible with biological constraints. Most importantly, the wide span
of time-scales observed for protein folding suggests a paradigm dis-
tinct from random sampling of all possible conformations. Various
mechanisms of limiting the conformational space have been pro-
posed, including a bias towards native-like interactions [5], formation
of intermediate states on the folding pathway [6], funneling into a
particular folding pathway [7] with optional errors [8], and folding
down the energy landscape through multiple pathways [9].
2.1. Chaperones limit the available conformational space
Molecular chaperones, by selectively interacting with certain se-
quence and structural elements, can both contribute to limiting the
conformational space and favor particular folding pathways. For ex-
ample, we traditionally consider that binding of hydrophobic se-
quences by HSP70 chaperones serves to protect nascent chains and
folding intermediates from aggregation, by shielding these recogni-
tion regions from intermolecular hydrophobic interactions [10]. How-
ever, another consequence of HSP70 binding may be retarding the
collapse of these hydrophobic regions into the core of the forming
protein. Shielding of HSP70-target peptides from intramolecular
hydrophobic interactions early in the folding process would favor a
different ﬁnal spatial arrangement of this sequence, compared to
the arrangement that could result if it was allowed to participate in
an early hydrophobic collapse. In fact, the hydrophobic residues
that are involved in misfolding and aggregation are often the same
residues that form chaperone recognition sites. For example, the
ER HSP70 chaperone, BiP, binds to immunoglobulin (Ig) light chain
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One of these two peptides is directly involved in the formation of amy-
loid ﬁbrils by the variable domain, as shown in [13]. Interestingly, these
two dominant BiP-binding sites are located in the center of each of the
two β sheets, and the BiP-binding residues face the core of the β sand-
wich in the folded protein [12]. The release of BiP from the variable do-
main is coupled to the formation of the stabilizing disulﬁde bond [11];
BiP binding then serves to delay the closing of the sandwich. Thus, by
retarding the incorporation of certain hydrophobic regions into the hy-
drophobic core, chaperone binding favors a different folding path lead-
ing to speciﬁc contacts. Finally, ATP-driven cycles of chaperone binding,
and enzyme-like actions of protein disulﬁde isomerases (PDIs) and pro-
tein prolyl isomerases (PPIs), also contribute to conformational remod-
eling during the folding process, by allowing proteins to escape
unproductive intermediate states stabilized by non-native interactions.
So far, we lack good understanding of how chaperones recognize such
stabilized states.
2.2. Consequences of vectorial synthesis
The vectorial synthesis of polypeptides provides yet another
means of restricting the conformational space, by controlling the
order of folding steps. Because the emergent nascent chain starts
folding concomitantly with synthesis, the folding opportunities for
α helices and β sheets are vastly different: helix-forming amino
acids are translocated sequentially and therefore are available imme-
diately to form all the interactions that stabilize helices. Formation of
β sheets, on the other hand, must be severely delayed by the translo-
cation process, since each peptide that would assume an extended
strand conformation must ‘wait’ until the other strands are synthe-
sized before hydrogen bonds can be satisﬁed. This difference implies
that if such secondary structure elements form the initial folding in-
termediates, then α helical proteins have a kinetic advantage in the
ER. This difference also explains why the peptide binding chaperones
of the HSP70 family evolved to bind extended β strand peptides. In
addition to structural elements like β sheets, the organization of cer-
tain domains may require slowing down or pausing their folding until
the entire domain has emerged from the translocon. For example, a
C-type lectin fold, present in multiple metazoan extracellular pro-
teins, has a loop-like form, connected at its base by a disulﬁde bond
and an antiparallel β-sheet formed by N- and C-terminal β strands
(β1, β5) coming close together [14]. In such arrangements, not only
does the N-terminal β strand need to be prevented from inappropri-
ately participating in the hydrophobic collapse, but the formation of
the disulﬁde bond by the cysteine in the N-terminus has to be
delayed as well. Other examples of such delay are the folding of inﬂu-
enza hemagglutinin [15–17] and chorionic gonadotropin β chain [18],
where binding of molecular chaperones is used to direct the folding
pathways in vivo.
Vectorial synthesis has another global effect on the folding options
available for large proteins. The organization of large proteins into a
series of independently folding domains restricts the conformation
space: as each domain folds, the number of options for the rest of
the sequence are reduced. However, the complexity of the proteome
and the oligomeric structure of many proteins mean that even this
simple rule may not be sufﬁcient, as discussed in the examples below.
3. Unique aspects of protein folding in the ER
The conditions for folding within the ER differ signiﬁcantly from
those in other cellular compartments like the cytosol, nucleus or
mitochondria. The molecular crowding in the ER is 3–6× higher
than in the cytosol [19], the redox potential is 1000× more oxidizing
[20], free Ca++ concentration oscillates and can reach 1 mM [21], and
carbohydrates and a glycosylation machinery are unique to the ER.These conditions impact the energetics and kinetics of protein folding
and provide the evolutionary pressure for the presence of specialized
enzymes and chaperones to facilitate folding in the ER. Indeed, the
most abundant luminal proteins (e.g. BiP, GRP94, PDI, HSP47 and
calreticulin, see Table 1) all function in protein folding. We review
the impact of these unique conditions ﬁrst, and then discuss how
the folding machinery ‘responds’ to them. Our main focus is folding
of proteins in the ER lumen and the folding of ER membrane proteins
is considered elsewhere.
3.1. Proximity to the membranes
One consequence of the vectorial translocation of the nascent
chain into the ER lumen is that it is positioned in proximity to the
membrane, which can have detrimental effects on folding. Negatively
charged membrane surfaces have been shown to inﬂuence conforma-
tional transitions and induce aggregation and ﬁbrilogenesis of Ig LCs
[22], lysozyme [23], and a proteolytic collagen fragment endostatin
[24], as well as a variety of non-secretory proteins [25]. As there is
no ER equivalent to the cytosolic ribosome-associated chaperones or
to chaperonins, the protection of the emerging nascent chain from in-
teraction with membrane surfaces and its channeling into folding
pathways is mediated by the close spatial proximity of the BiP mole-
cules which gate the translocon [26] and the oligosaccharide transfer-
ase [27].
3.2. Folding in the viscous luminal environment
One constraint on folding in the ER lumen is its high macromolec-
ular density, which was measured to be 3–6 fold higher than in the
cytosol and 9–18× higher than in typical aqueous buffers [19]. The
viscosity of the ER lumen is high not only because of the presence
of many proteins in various states of folding, including the high
concentration of ER-resident chaperones, but also because of other
macromolecules, estimated to occupy up to 30% of the volume
[28]. Nonetheless, the diffusional mobility of GFP-tagged chaperones
is only moderately slowed in the ER compared to the cytosol
(E.L. Snapp, personal communication). The viscous environment is
one evolutionary reason for molecular chaperones, whose activity
imposes a timing sequence on the folding pathway that is not emu-
lated in monodisperse in vitro systems. Molecular crowding clearly
also affects the activity of the folding machinery, for example the
enzymes that trim glycans [29].
3.3. Consequences of glycosylation
Carbohydrates serve several roles in protein folding. First, because
of their hydrophilic nature, carbohydrates increase the solubility of
the glycoprotein. Second, they generally mark the surface of folding
modules and are not buried within them. Third, they make the pro-
cess of translocation across the ER membrane less reversible by in-
creasing the energy barrier to back-translocation. Apart from these
general roles, however, carbohydrates also affect protein folding, al-
beit in individualized and idiosyncratic ways. Detailed studies with
glycoproteins whose Asn-linked glycosylation sites were mutated
systematically showed that in many cases glycosylation is needed
for proper folding: under-glycosylated proteins form intracellular ag-
gregates and are retained in the ER [30–32]. Somewhat paradoxically,
however, almost no individual glycan is necessary for folding of VSV G
protein or inﬂuenza hemagglutinin [33,34]. Only one of seven hemag-
glutinin glycans, attached to Asn81, created a kinetic barrier to fold-
ing [32], and even this glycan effect could not be detected in
another set of experiments [34]. Among the highly homologous
MHC class I molecules, some are sensitive to the presence of glycans
[35], whereas others fold equivalently in the presence or absence of
the carbohydrates [36]. Furthermore, even proteins that are normally
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glycans [37]. Thus, the ‘rules’ that govern the interplay between gly-
cosylation and folding are at present still poorly understood. In part,
the explanation lies in the observation that aromatic and hydrophobic
amino acids are over-represented near those N-glycosylation sites that
are important for proper folding [38]. This correlation was shown
experimentally to be important because in such ‘aromatic sequons’
the aromatic side chain interacts with the ﬁrst N-acetylglucosamine of
the glycan, and grafting such sequons onto non-glycosylated proteins
increases their stability [39]. Table 2 provides comparative examples
from several proteins where some N-glycosylation sites are known to
impact, but others are dispensable for folding. This compilation further
reinforces the potential relevance of neighboring hydrophobic residues.
We suggest that for certain sites, an additional role for attachment of
glycans and the subsequent associationwith chaperones is to overcome
the thermodynamic tendency of hydrophobic patches in close proxim-
ity to these sites to avoid display on the protein surface, thus nucleating
particular folding pathways.Table 1
Relative of abundance of selected ER proteins.
Protein Function 3T3a
Chaperones
BiP = GRP78 HSP70 family chaperone 100.00
GRP170 = Hyou1 BiP exchange factor 11.14
Sil1 = BAP BiP exchange factor 0.96
ERdj3 = DnaJB11 J domain co-chaperone 4.21
ERdj5 = DnaJC10 J domain; reductase 1.17
P58ipk = DnaJC3 J domain co-chaperone 1.35
Sec63 Translocon J domain 0.37
ERdj1 = MTJ1 = DnaJC1 J domain co-chaperone 0.09
HSP47 = Serpin H1 Collagen speciﬁc 204.29
GRP94 HSP90 family chaperone 63.44
CNPY3 Client-restricted GRP94 co-chaperone 0.94
Prolyl isomerases
Cyclophilin B CsA-sensitive folding/ERAD facilitator 204.00
FKBP13 FK506/rapamycin binder 10.02
FKBP23 FK506/rapamycin binder 1.74
FKBP65 FK506/rapamycin binder 5.25
Glycoprotein quality control
Calnexin Membrane lectin chaperone 19.76
Calreticulin Lumenal lectin chaperone 39.45
UGT1 Glucosyl-transferase 2.91
Ribophorin I Oligosaccharyl transferase complex 17.96
Ribophorin II Oligosaccharyl transferase complex 15.23
Glucosidase IIα Glycan trimming 14.33
Glucosidase IIβ Glycan trimming 9.50
OS-9 ERAD lectin N.D.
Erlectin = XTP3-B ERAD lectin
Mannosidase Man1b1 Glycan trimming 0.18
EDEM2 ERAD lectin N.D.
EDEM3 ERAD mannosidase N.D.
Redox proteins
Ero1l Redox generation 5.28
ERp44 5.30
ERp29 9.37
PDIA1 = PDI Isomerase and chaperone 78.66
PDIA3 = ERp57 Glycoprotein preference 82.51
PDIA4 = Erp72 16.09
PDIA5 = Pdir 1.16
PDIA6 = P5 30.95
Prdx4 Redox generation 18.74
Data derived from published quantitative proteomic methods. The abundance of BiP/GRP7
normalized to it.
a 3T3 proteomic data from [108].
b HeLa cell and Caco2 cell proteomics from [232], using peptide spectral counts. Similar
c CD4-positive dendritic cells, peak intensity counts reported in [231].
d Values are from [107,234] and are based on puriﬁcation of proteins.3.4. Folding in an oxidizing environment
A general property distinguishing proteins that fold in the ER from
cytosolic proteins is the preponderance of disulﬁde bonds. Cys residues
in newly synthesized secretory polypeptides tend to oxidize in the ER
lumen because of its high oxidative redox potential. In the past decade
there has been a major shift in the understanding of the redox buffer in
the ER, from an emphasis on a glutathione-buffering system [20] to the
realization that the eukaryotic ER uses a mechanism similar to the bac-
terial periplasm [40] to maintain its redox potential: a protein-based
relay of oxidation/reduction reactions (Reviewed in [41,42]). The relay
involves Ero1, a conserved FAD-dependent enzyme, which is oxidized
by molecular oxygen and in turn acts as a speciﬁc oxidant of protein
disulﬁde isomerase (PDI), which then directly oxidizes disulﬁde bonds
in folding proteins. In addition to Ero1, PDIs can be oxidized by
peroxiredoxin IV, whichmetabolizes the H2O2 formed by the Ero1 reac-
tion, couples this oxidation to disulphide formation [43–45], and pro-
vides a parallel pathway for oxidative folding in the ER [46].HeLab Dendritic cellsc Caco2c Pancreatic RERd
100.00 100.00 100.00 100.00
12.22 20.62 18.18 12.00
0.34 0.11 0.55 0.10
7.65 5.38 6.09 5.80
0.89 1.01 0.95 40.00
3.20 1.94 3.69
9.98 0.61 6.88 39.60
0.47 N.D. 1.15 7.20
62.09 N.D. 81.47
90.96 70.65 123.48
2.91 2.85 4.44
165.00 34.00 208.00
9.57 7.00 10.96
1.05 N.D. 0.00
11.06 3.67
56.75 17.84 97.65
129.61 35.40 164.94
3.98 65.11 3.72
N.D. 14.87 42.70
24.64 8.54 16.66
33.94 28.24
32.74 4.76 33.61
0.31 0.71
0.66 0.00 0.44
0.40 0.31
0.04 0.06
0.28 0.11
0.02 0.40 15.47
11.06 5.10 19.42
31.96 18.75 47.32
109.76 27.69 91.24
70.26 64.81 91.58
28.58 15.01 43.87
1.34 0.13 3.92
21.35 30.34 36.83
31.90 2.35 6.88
8 in each dataset was set to 100 and the expression values of the other proteins were
results were reported by [233], based on SILAC quantitation.
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lead to oxidative stress through the production of reactive oxygen
species and oxidized glutathione. That cellular oxidative stress affects
protein folding is shown, for example, by the slower maturation of
LDL receptor under high H2O2 concentrations [47].
Disulﬁde bonds are very important in dictating folding pathways,
because they form covalent interactions that stabilize folding inter-
mediates [48] and severely restrict the landscape of available confor-
mations. Formation of disulﬁde bonds begins very early in the life of
the protein, sometimes as soon as the required Cys residues are avail-
able in the lumen [49,50]. On the other hand, some disulﬁde bonds do
not form until much later in the folding sequence, even within the
same domain [16,51]. Such dichotomy suggests that in vivo there
are mechanisms that selectively delay some oxidation steps. As a fur-
ther apparent contradiction, proteins can undergo post-translational
oxidation and achieve the same native structure as with co-
translational oxidation. Addition of reducing agents to the medium of
live cells prevented disulﬁde bond formation in newly synthesized in-
ﬂuenza hemagglutinin or asialoglycoprotein receptor and reduced the
already oxidized glycoproteins inside the ER. When the reductant was
washed out, the reduced proteins rapidly oxidized, folded correctly
and assembled [52,53]. These examples show that apparently oxidation
follows the samepathwaywhen it occurs post- or co-translationally and
underscore the concept that in most cases disulﬁde bonds serve to sta-
bilize a local fold, achieved by multiple cooperative interactions, rather
than to initiate the folding. In support of this view, mutagenesis exper-
iments show that lysozyme can be reasonably well folded even without
some disulﬁde bonds [54] and that if an Ig ismade stable enough via ge-
netic engineering, it can withstand the removal of its disulﬁde bonds
[55].
All the above observations also indicate the need for precise con-
trol over protein oxidation in the ER. As discussed in Section 5.4, the
PDIs are capable of shufﬂing disulﬁde bonds, stabilizing proper inter-
mediates, and resolving aberrant disulﬁde bonds. One indication of
the importance of the control over disulﬁde bonds is that the level
of expression of PDIs in pancreatic β cells is proportional to insulin
expression, consistent with oxidative folding being an important as-
pect of this hormone's biogenesis [56].
3.5. Inﬂuence of calcium on folding
The ER is a major calcium store in the cell and therefore has to
respond to the metabolic needs of the cell by rapid changes in free
luminal Ca++ levels. This must impact protein folding in the lumen,Table 2
Correlation between N-glycosylation sites that are important for folding and hydrophobic r
Protein Sequence Folding
Mouse tyrosinase VFYN86RT Necessa
Mouse tyrosinase GDEN230FT Dispens
Mouse tyrosinase RTAN337FS Dispens
Mouse tyrosinase IFMN371GT Necessa
Human MHC class Ib GYYN86QS Necessa
Human α3 integrin AIYVFMN349QS Impede
Rat adenylate cyclase 6 RQIN791YS Dispens
Rat adenylate cyclase 6 ASSN876ET Dispens
Human PDIA2 TLKFFRNGN127RT Dispens
Human PDIA2 ILNHLLLFVN248QT Importa
Human PDIA2 AAPFPEPPAN516ST Dispens
Rat ICAM-5 RGGSLWLN54CS Necessa
Rat ICAM-5 ETSLRRN74GT Dispens
Human chymotrypsin C SLQYLKN52DT Necessa
Human chymotrypsin C LNCQLEN226GS Dispens
Sequences upstream of N-glycosylation sites are shown with aromatic and aliphtic residues u
were chosen.
a Designation of the glycosylation site as necessary for proper folding, important but not
b The sole site in human HLA; rodent class I are functional without their N-glycosylation.
prediction made in [166].but the information available is surprisingly superﬁcial. In principle,
Ca++ can inﬂuence folding directly through binding to amino acids'
side chains. Perturbation of Ca++ levels also affects folding of luminal
proteins indirectly, in a manner more pertinent for this review:
several members of the folding machinery in the ER, including
GRP94, BiP, calreticulin, ERp72, PDIA1, and PDIA6, are Ca++ binders
(e.g. [57]) and their interactions can be modulated by Ca++, as sug-
gested by interaction experiments [58–60]. The refolding activity of
ERp72 and PDIA6 [61] and the peptide-binding activity of GRP94
[62] are modulated by Ca++. Whether folding of a given protein is af-
fected by Ca++ directly or indirectly, is not easily predictable. Clearly,
different secretory proteins respond differently to Ca++ changes: de-
pletion of Ca++ has no effect on folding or secretion of albumin, but
severely inhibits asialoglycoprotein receptor and α1-antitrypsin mat-
uration [63,64]; The initial assembly step of large and small subunits
of Heymann nephritis antigenic complex is calcium-dependent, but
a later step is not [65]. Under low luminal Ca++, thyroglobulin is
retained in the ER, but interestingly, it exits the calnexin/calreticulin
cycle prematurely, while its interactions with the other chaperone
axis of BiP and GRP94 is stabilized and prolonged [66,67]. Conversely,
for other proteins, like TCRα, chelation of Ca++ causes release from
BiP [60]. Thus, the roles of chaperones can change depending on the
Ca++ concentration in the ER, but the resulting effects depend on
the substrate protein.
3.6. A distinct spectrum of folds in secreted proteins
All the constraints on folding in the ER that are discussed here pre-
sumably provided evolutionary pressure that favored certain types of
folds in secreted proteins and cell-surface receptors. There are several
examples of types of domains that are over-represented in secretory
proteins and under-represented in other types of proteins. One exam-
ple is the immunoglobulin fold, which consists of a sandwich of two
β-sheets with a Greek key topology and is found in hundreds of pro-
teins of different functions, including integrins, adhesion molecules,
interleukin receptors, receptor tyrosine kinases and histocompatibili-
ty proteins. The immunoglobulin fold is, however, under-represented
among cytoplasmic proteins, and when it is found there, it is one
subtype of the immunoglobulin fold (e.g. [68]). A second example is
the ligand-binding domain of the low-density lipoprotein receptor.
It is ~40 residue long with little recognizable secondary structure or-
ganized around a calcium ion [69], stabilized by Cys residues that
form three disulﬁde bonds [69,70]. Variations of this ligand-binding
domain are found in a many kinds of cell surface receptors andesidues neighboring them.
a Comment Ref.
ry [38]
able
able Necessary in human tyrosinase [235,236]
ry
ry [237]
s Gain-of-function mutant [238]
able But needed for function [239]
able But needed for function
able [240]
nt
able
ry [241]
able
ry Not for function [242]
able
nderlined. Where information is available, sites that affect folding and sites that do not
essential, impeding or dispensible.
Note that all sites are farther than 50 amino acids from the N-terminus, satisfying the
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because of the requirement for oxidation of cysteines. Yet a third ex-
ample is the EGF-like domains, present on a large number of mem-
brane or extracellular proteins, but not in cytosolic proteins. These
30–45 residue-long domains consist of a small β sheet and a ﬂexible
loop, with three disulﬁde bonds stabilizing the structure [71].
4. Folding intermediates in vitro and in vivo
In vitro folding experiments often describe proteins with folding in-
termediates at equilibrium, which can be trapped by non-physiological
conditions, like drastic pH shifts. In contrast, folding in vivo is often
made non-reversible by post-translational modiﬁcations, such as pro-
line or disulﬁde isomerization, which are driven by enzymes. Tyrosi-
nase, a glycoprotein where the carbohydrates are essential for the
native fold, exhibits several inactive intermediates, at least two of
which are recognized by calnexin. If the association with calnexin is
prevented, folding is actually more rapid, but the resulting protein
fails to bind copper and is inactive [72]. In the large family of proteinase
inhibitors, some intermediates are kinetically trapped and previously
acquired disulﬁde-linked structures need to unfold in order to progress
to the native state [73].
Whether through chaperone action or via the biophysical condi-
tions that exist in the ER, restriction and simpliﬁcation of the folding
pathway is sometimes inherent in the protein: while exponential
functions are required to describe the folding kinetics of phospho-
glycerate kinase in vitro, when this cytosolic protein is engineered
to fold in the ER, the measured folding kinetics are more two-
state-like, reﬂecting the modiﬁcations imposed by the intra-luminal
conditions [74].
The in vivo conditions sometimes dictate a folding pathway that is
not only simpler but actually different from that observed in vitro. For
example, although each of the two domains of immunoglobulin light
chains can fold autonomously when expressed alone, during immu-
noglobulin biosynthesis in vivo, the variable domain, which is
N-terminal and emerges ﬁrst, folds after the constant domain [75].
The reason is that BiP continues to engage its V domain peptide bind-
ing sites and, if this interaction persists, the light chain folding inter-
mediate is targeted for ER-Associated Degradation (ERAD) [12,13].
Most light chain variants that form amyloids are mutated in the var-
iable domains and do not complete folding in the cell. The partner
heavy chain also has an important in vivo intermediate where the
ﬁrst constant domain is slow to fold [76]. Folding of this domain is
coupled to assembly with the light chain, illustrating the importance
of folding intermediates in vivo. Neither of the above folding interme-
diates would have been predicted by in vitro techniques and they
illustrate how the complex luminal environment dictates the path
to productive folding.
The insulin fold family provides an example for a related concept:
intermediate structures necessary for attaining the native state, but
not for activity of the protein. The N-terminal 8 amino acids of the
B chain dictate the foldability of proinsulin, but once the native state
is achieved, this peptide is dispensable for native structure, activity, or
stability of mature insulin [77,78]. Thus, the folding process could, in
itself, provide an evolutionary pressure for sequence conservation.
4.1. Oligomeric protein assembly
Once domains and polypeptides fold, many proteins require assem-
bly of subunits before they are biologically active and are competent for
export from the ER. Native viral glycoproteins often form non-covalent
trimers that assemble in the ER [79] in an ATP-dependent fashion [80].
B and T cell receptors or MHC proteins assemble from 2 to 7 subunits
into the biologically active entity before they exit the ER. In either
case, there is at least one subunit whose folding is a pre-requisite for
assembly: in the case of B cell receptor, the folding of the heavy chainis completed only upon subunit assembly [81,82] and in the case of
the T cell receptor—only upon folding of the CD3 epsilon subunit [83].
A similar situation is observed for nicotinic acetylcholine receptor and
likely many other receptors [84]: by stabilizing and sequestering sub-
units during assembly, chaperones like calnexin, BiP and ERp57 regulate
the levels of assembled functional receptors. In general, unassembled
subunits either aggregate or are targeted to degradation via the ERAD
or autophagy pathways, but are not transported to the Golgi complex.
Intermediates do not only deﬁne the folding of protein domains or
polypeptide chains, but are also characteristic of oligomeric assembly
of many proteins. For example, the Heymann nephritis antigenic
complex assembles in two discrete stages. First, a large glycoprotein
(gp330) associates with a 44 kDa subunit early after synthesis, and
then, >60 min after synthesis, a larger hetero-oligomer forms, still
before acquisition of Endo H resistance [65].
What features enable the cell to discriminate between free sub-
units and assembled oligomers? No global answer can yet be pro-
vided, but in individual cases there are examples of features that
may operate. As mentioned above, during Ig assembly there is a
mechanism for coupling the folding of a ‘sentinel’ CH1 domain
whose folding is retarded [85], to assembly of heavy and light chains
by coordinating the formation an intra-domain disulﬁde bonds with a
disulﬁde linking the two chains [51,81], thus releasing chaperones
and folding enzymes ([85,86], and see below). T cell receptor assem-
bly depends heavily on hetero-pairing of subunits via transmembrane
domains that contain charged amino acids [87–90]. If left unpaired,
these subunits do not assemble and are dislocated from the ER mem-
brane. The presence of unsatisﬁed intramembrane charge prevents
stabilization of the unassembled subunits via homo-oligomerization
and maintains them in a retrotranslocation-competent state [91].
The unassembled α chains can be retained in the ER by BiP, in
Ca++-dependent fashion [60].
In glutamate transporters, an evolutionarily conserved arginine-
based motif acts as an ER retention signal, while a luminal leucine
motif is required for suppression of this signal and allows trafﬁc to
the Golgi complex [92]. This motif is likely a subject to conformation
modulation that could occur upon subunit assembly. Another case of
conformational control in the ER is the maturation of AMPA receptors
to acquire ligand-binding activity [93]. The extracellular region that
distinguishes isoforms of AMPA receptor can interact with binding
proteins such as stargazin, or with other luminal isoform-speciﬁc
proteins, to determine whether a transport-incompetent subunit
has assembled sufﬁciently to trafﬁc to the cell surface [94].
5. Chaperone networks in the ER
The complex demands of orchestrating the folding of secreted and
membrane proteins require at least 10 ubiquitously expressed chap-
erones and some client-speciﬁc ones (Table 1, and other reviews in
this issue). These chaperones do not generally work alone, but rather
fulﬁll each task by forming transient networks of chaperones, cofac-
tors and folding enzymes that operate in concert. The composition
of these networks appears to adapt to the needs of the folding clients.
5.1. The BiP network
5.1.1. Client recognition
The most abundant chaperone network and the one involved with
most client proteins is the BiP/GRP78 network (Table 1). BiP is a
multifunctional chaperone, involved in nascent chain translocation,
folding of polypeptides, resolving and removal of misfolded proteins
and monitoring the ER stress transducers (entries in [95]). Consistent
with these multiple functions and the variety of known client pro-
teins, BiP is an essential protein. In the cell, it is usually not possible
to reduce BiP expression below 40% of its normal level [96] (Argon,
unpublished data), and in the whole organism, BiP deletion leads to
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primary biochemical activity of BiP/GRP78, which uniﬁes all these
functions, is binding to 7–11 residue peptides that in the folded
state form β strands and whose sequences tend to have alternate
hydrophobic residues [97,98]. These residues are buried in the interi-
or of the native fold but are exposed in early intermediates or in
misfolded proteins [12,99]. The inherent afﬁnity of BiP for peptides
is in the range of 1 to100 μM, as appropriate for a chaperone that
had evolved for transient interactions. Higher afﬁnity interactions
would have inhibited folding altogether. It is estimated that a BiP-
binding site would be created in a random sequence once every 36
amino acids [98]. This frequency would explain why BiP has a large
number of client proteins. Yet, domains that have predicted BiP bind-
ing sites do not always employ them to a signiﬁcant degree in the cell,
and this accounts for a chaperone-directed folding sequence in which
BiP dictates the path of folding [13,100]. This can be exempliﬁed
by BiP binding to Ig light chain molecules: although light chain is
predicted to have >5 binding sites in each of the variable (VL) or con-
stant (VC) domains [12], BiP only binds unoxidized VL domain in cells,
with no detectable binding to the constant domain [86,101](Argon,
unpublished data). Furthermore, two out of the potential ﬁve binding
sites in VL are sufﬁcient to explain the BiP-light chain interaction [12].
A combination of in vivo and in vitro folding studies revealed that the
constant domain folds rapidly and stably even in the absence of an
intradomain disulﬁde bond [75,86]. Thus, the simple presence of a
BiP-binding site on a nascent chain does not ensure that BiP will
bind and play a role in its folding. Instead, it appears that the rate
and stability of protein folding determines whether or not a particular
site is recognized, with BiP preferentially binding to proteins and
domains that fold slowly or are less stable.
5.1.2. Regulation of ATPase cycle
The action of BiP in folding reactions, like its activity in other pro-
cesses, requires nucleotides. Since there is no in situ ATP generator,
the ER lumen depends on mitochondrial ATP that is imported into
the ER via a 56 kDa permease [102,103]. In the lumen, ATP is needed
for the action of various proteins. Binding of BiP to clients is very fast
in the ATP-bound state, but hydrolysis must occur to stabilize the
binding. Exchange of ADP to ATP is then needed to accelerate the re-
lease of the client protein. The peptide-binding and release activity of
BiP thus requires its ATPase cycle [104], but, because BiP's inherent
ATPase activity is low and the spontaneous transition between the
two states is extremely slow, its ATPase cycle depends on cofactors.
At least 7 proteins can modulate BiP's ATPase cycle: Four HSP40-
family proteins containing a J domain, two nucleotide exchange
factors (Sil1/BAP and GRP170/ORP150), and ERdj5, a PDI that also
possesses a J domain. The J domain proteins stimulate BiP's ATP hy-
drolysis and thus enhance BiP's interaction with misfolded proteins,
while Sil1 and GRP170 exchange ADP for ATP so that BiP can dissoci-
ate from them more readily. The combined action of J proteins and
nucleotide exchange factors creates a cycle of binding and release
that is key to the mode of action of the BiP machine (reviewed in
[105]).
GRP170 can form a stable complex with BiP in the absence of ATP,
mediated through contacts between their nucleotide binding do-
mains [106]. This association decreases the afﬁnity of nucleotide
binding to BiP but does not stimulate its ATPase activity [106]. It is
noteworthy that there is a 9-fold excess of BiP over GRP170 and
an even larger excess over Sil1 or each of the J domain proteins
[107,108] (Table 1), underscoring that these cofactors may be limiting
components and must operate catalytically. Alternatively the cofac-
tors may be only needed for a very limited set of substrates, but this
seems unlikely, since the BiP cycle and not stable association seem
to be the norm. Although GRP170 is an HSP70 family protein and
has domains that can bind peptides [109,110], no direct role has yet
been demonstrated for GRP170 in folding client proteins in vivo,though it is associated with immunoglobulins in B cells [111] and
with misfolded mutants in other cells [112]. These interactions of
GRP170 with both BiP and misfolded species may serve to target BiP
to a speciﬁc pool of client proteins.
J domain proteins may also adapt the BiP complex to the demands
of the speciﬁc task. Thus, ERdj3, can bind directly to several nascent,
unfolded and mutant secretory proteins, even without BiP [113].
After ERdj3-client binding, BiP joins the complex, which leads to dis-
sociation of ERdj3 and the client polypeptide and concomitant stimu-
lation of BiP's ATPase activity before folding is completed [113]. The
higher ATPase activity converts BiP to its high-afﬁnity state for clients,
so ERdj3 seems to present the client for BiP-dependent folding [114].
Similarly, P58(IPK)/DnaJC3 presents other clients for BiP-dependent
folding [115]. On the other hand, binding of the J protein ERdj5 to
misfolded α1-antitrypsin, with its subsequent recruitment of BiP
and activation of its ATPase, leads to reduction of the client's disulﬁde
bond by the PDI activity of ERdj5 and its subsequent targeting by BiP
and EDEM1 to disposal via ERAD [116]. How different J domain pro-
teins target BiP is not understood. Although the various J proteins
can bind alternatively to the same surface on BiP, the exact modes
of binding are not identical, since a mutation in this binding region
of BiP abolishes interactions with some J proteins but not with others
[117].
5.1.3. Functional consequences of BiP binding
The usual activity of BiP involves ATP-dependent cycles of binding
and release of the substrates. The cycling is mediated by the continual
exposure of hydrophobic BiP binding sites on the immature folding
intermediates. One of the exceptions to the ‘canonical’ binding and
release action cycle is the BiP-substrate interaction that is sufﬁciently
prolonged so as to be stable under physiological conditions. A prime
example is BiP interaction with the CH1 domain of Ig heavy chains
[85]. This domain is intrinsically disordered in vitro, which sets it
apart from other Ig domains. CH1 folds only upon interaction with
the CL domain of the Ig light-chain. Structure formation proceeds
via a trapped intermediate and can be accelerated in vitro by the
ER-speciﬁc peptidyl-prolyl isomerase cyclophilin B [85]. BiP recog-
nizes incompletely folded states of the CH1 domain and competes
for binding to the CL domain. Unlike BiP binding to many other sites
in the Ig molecule [12,13], its binding to the CH1 domain is persistent,
ensuring that CH1 remains unoxidized long after other domains have
folded [81]. The ‘purpose’ of this built-in delay is to coordinate
the formation of the intradomain disulﬁde with that of the inter-
subunit disulﬁde bond [51,82], a key step that links completion of
the heavy chain subunit folding to the assembly of heavy and light
chains [51,85]. In vivo experiments demonstrate that these steps,
including association with a folded CL domain and isomerization of
a conserved proline residue, are essential for antibody assembly and
secretion in the cell [85]. When chain assembly cannot be completed
because the right partner is absent, or when a protein cannot fold due
to mutation, the persistent BiP association leads to retention and/or
ERAD [51,76,81,118]. The retention of incompletely folded proteins
is therefore a consequence of the normal action of the BiP system.
Nonetheless, what determines persistent BiP binding to the sites in
CH1 vs. short-lived interactions with other sites on the same molecule
is not yet known.
In addition to the folding trajectories of their client proteins,
chaperones like BiP can inﬂuence their aggregation pathways [119].
A mechanistic insight into this process is provided by considering
the role of BiP in the folding and aggregation of the amyloidogenic
mutant immunoglobulin light chain [120]. Of the two dominant
BiP-binding sites important for the folding of VL, one is directly in-
volved in the formation of amyloid ﬁbrils, as the synthetic peptide
containing this site speciﬁcally inhibits VL amyloidogenesis [12,13].
Thus, binding to the same binding site mediates BiP's function in pro-
moting the efﬁcient folding of VL in the cell and in the prevention of
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the reactivity of the anti-oligomer antibody A11, which, in addition
to recognizing aggregated forms of several dissimilar proteins, also
recognizes a subset of molecular chaperones, including members of
the HSP70 family [121]. A11 binding to these chaperones can inter-
fere with the suppression of aggregation or the refolding of their
substrates [121]. Therefore, increased competition for such a chaper-
one from other substrates, particularly if uncompensated for by a
stress response, may favor a shift from productive folding toward
amyloidogenesis and the formation of toxic species by the disease-
associated protein.
5.1.4. Organismal roles of the BiP network
While BiP is essential in all cells, none of its associated J proteins
seem to be essential in metazoa, and as far as we know none is a
generalist J protein. Though some of them can bind misfolded poly-
peptides directly (e.g. ERdj3 [113] or MTJ1 [122]), others function
without client binding, and yet others, like Sec63, are speciﬁc not
for protein folding, but rather for translocation across the ER mem-
brane. Considering the important role of the J domain proteins in reg-
ulating BiP's ATPase cycle, deletions of two J proteins in the mouse
have surprisingly speciﬁc phenotypes. Deletion of ERdj5 leads to a
pronounced salivary gland phenotype, consistent with failure of fold-
ing of amylase that induces persistent ER stress response [123]. This
phenotype of ERdj5 −/− mice is very tissue-speciﬁc, since plasma
cells or pancreatic β cells, which are also professional secretory
cells, are not affected signiﬁcantly. On the other hand, deletion of
mouse P58(IPK) has a β cell-speciﬁc phenotype [124]. The absence
of phenotype in unaffected cells may be due to compensation for
the loss of speciﬁc J domain protein by an unknown component, po-
tentially pointing to a redundancy in the J domain proteins. Alterna-
tively, the cell-speciﬁc dependence on a given J domain protein may
be dictated by the speciﬁc protein clients expressed in these cells,
pointing to much more specialized roles of these proteins.
Mutations in the Sil1 nucleotide exchange factor [125] cause
Marinesco–Sjogren syndrome (MSS) in humans [126,127] and ataxia
and neurodegeneration in woozy mouse (wz) [128]. Since Sil1, like
BiP and the J proteins, is expressed ubiquitously, this pathological pre-
sentation suggests selective vulnerability of certain cell types and tis-
sues, most notably the cerebellum. In wz mice, loss of Sil1 causes ER
stress and accumulation of ubiquitinated proteins in cerebellar Purkinje
cells, leading to degeneration and apoptosis [128]. Furthermore, even
within Purkinje cells there is differential sensitivity to loss of this chap-
erone, as Purkinje cells in the vestibulocerebellum of wz mice are
spared. Since Sil1 functions to regulate the ADP to ATP exchange, and
thus the chaperone cycle of BiP, the reasons for such selective vulnera-
bility are again not immediately obvious. One potential explanation is
that another BiP nucleotide exchange factor, GRP170/ORP150 (Lhs1)
may be redundant with Sil1 and thus compensates for its absence in
protected cells [129]. However, ORP150 is upregulated in affected
Purkinje cells of thewzmouse, so this upregulation is apparently insuf-
ﬁcient to protect the cells [130]. On the other hand, early ectopic over-
expression of ORP150 rescues ER stress, protein aggregation, and
neurodegeneration, while its down-regulation exacerbates these phe-
notypes [130].
A fascinating result is that inactivation of one of the DnaJ pro-
teins, P58(IPK)/DnaJC3, which promotes the ATPase activity and
substrate loading of BiP [115,131], also attenuated the phenotypes
of Sil1−/−mice [130]. This result supports the view that disturbance
in the BiP chaperone cycle is a cause of the neurodegeneration and
other phenotypes in the wz mouse (and by extension, in MSS
patients). The simultaneous absence of both the ATPase stimulating
activity of P58(IPK) and the nucleotide exchange activity of Sil1 is
predicted to decrease cycling of BiP, at least with respect to the spe-
ciﬁc set of substrates that the two co-chaperones may recognize.
Thus, rescue of Sil1 deﬁciency by deletion of P58(IPK) points tothe imbalance between the two opposing regulators of the BiP chap-
erone cycle as the potential etiological factor, rather than the deﬁ-
ciency of BiP chaperone activity per se. Since the ERdj5 knockout
was not tested for genetic interaction with Sil1, it is not yet known
whether the rescue property of the P58(IPK)-deﬁcient strain is
unique to this J protein, or is shared by all.
Another non-obvious result is that deletion of P58(IPK) by itself,
unlike deletion of Sil1, does not cause brain pathology or ataxia,
suggesting that sensitivity to the imbalance between J proteins and
nucleotide exchange factors may be one-sided and cell-speciﬁc. The
deletion of P58(IPK) does cause pancreatic β cell failure, due to per-
sistent UPR [124], but the ability of Sil1 deﬁciency to mitigate the β
cell phenotype was not reported [130]. Thus, the sensitivity to the im-
balance between J proteins and exchange factors may be one-sided.
In addition to the differential sensitivity of Purkinje cells to Sil1
depletion, there is evidence that they are also generally intolerant of
protein misfolding in the ER. A missense mutation (Ser658 to Pro)
in a ubiquitously expressed ERAD protein, SEL1L, in dogs leads to se-
lective cerebellum-restricted neurodegeneration with marked loss of
Purkinje cells [132]. As expected based on the role of SEL1L in disposal
of misfolded proteins from ER, the affected Purkinje cells activated
strongly the ER stress response [132]. Yet a third example of selective
sensitivity of these cells can be seen in a mouse carrying the sticky
(sti) mutation—a missense mutation in the editing domain of the
alanyl-tRNA synthetase gene, which leads to mistranslation and possi-
bly misfolding of many cellular proteins [133]. For unknown reasons,
this mutation affected Purkinje cells selectively, causing accumulated
ubiquitinated inclusions, increased expression of cytoplasmic chaper-
ones and also activated the ER stress response. Persistent CHOP expres-
sion, which is thought to be associated with pathological levels of ER
stress, was seen through the onset of degeneration, suggesting that per-
haps the low but chronic levels of proteinmisfoldingwere not tolerated
in these susceptible cells [133]. Therefore, the conspicuous sensitivity
of Purkinje cells to slowing the BiP cycle may be indicative of their
increased sensitivity to altered proteostasis, as in the examples of
mistranslation and defective ERAD.
5.2. GRP94
5.2.1. Client recognition
A chaperone that is often associated with the BiP complex is GRP94,
the single HSP90 family representative in the ER [134]. When working
on a folding pathway together with BiP, GRP94 usually is the second
chaperone in the sequence, thought to engage late folding intermedi-
ates (e.g., Ig [11,135,136], Tg mutant [137,138]), and this distinction
seems to be due to different structural cues to which GRP94 is sensitive.
Unlike extended peptides with speciﬁc sequence features that are rec-
ognized by BiP, no sequence or structural motives have emerged for
GRP94. This may simply reﬂect the relatively restricted number of
known GRP94 client proteins; alternatively, GRP94 may have a more
complex recognition mode, similar to the HSP90's ability to recognize
metastable and near-native domains. The rules of engaging GRP94
with clients are also still unknown; the chaperone activity of GRP94 in
vivo requires ATP [139], but unlike the BiP complex, no accelerator of
ATPase nor an exchange factor has been discovered for GRP94. The
only identiﬁed co-factor for GRP94 so far is CNPY3, which is widely
expressed (Table 1), but is a client-speciﬁc co-chaperone that does not
modulate the ATPase cycle of GRP94 [140].
The order of BiP-GRP94 interaction mirrors the HSP70–HSP90 axis
in folding of cytoplasmic clients [141], and the position of GRP94 as
the second in the sequence likely accounts for its restricted clientele.
BiP's sequence-dependent recognition of slow folding or unstable
domains may account for most of the chaperone-dependent secretory
proteins that are not engaged with the calnexin–calreticulin cycle;
only a subset of these proteins is subsequently engaged by GRP94,
guided by the yet unknown thermodynamic or structural features.
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the folding options of a client and direct it to a preferred pathway.
While it is not clear whether GRP94 interacts physically with BiP,
there is obviously a strong functional interaction between them,
as demonstrated by the upregulation of expression of either chaper-
one when the other is silenced genetically or inhibited pharmacolog-
ically [142].
5.2.2. Organismal roles of GRP94
The GRP94−/− mouse provides a remarkable example of speciﬁc,
client-restricted phenotype due to the lack of a chaperone. The em-
bryonic lethality at E6.5–7.5 coincides with the developmental time
when mesoderm induction occurs and when IGF-II, a client which is
totally dependent on GRP94 activity is ﬁrst expressed [143]. Another
client, Ig, is not so strictly dependent on GRP94, and indeed targeted
deletion of the chaperone in B lineage cells does not appreciably
depress the circulating levels of antibodies [144]. The phenotypes of
tissue-speciﬁc deletion of GRP94 also reﬂect its client interactions:
deletion in skeletal muscle mostly affects the muscular growth
pathway that depends on IGFs [145], and thrombocytopenia due to
deletion in hematopoietic cells is caused by the effect on platelet gly-
coprotein Ib-IX-V complex [146]. Lack of GRP94 in a B cell line leads
to a failure to respond to bacterial endotoxins, due to a selective
defect in maturation of Toll-like receptors and integrins [144,147].
In all of these studies, GRP94 was not required for the cellular viabil-
ity, which again is consistent with its selectivity.
Like GRP94, at least one other ER chaperone recognizes advanced
folding intermediates. HSP47 preferentially recognizes Gly-X-Y re-
peats in the triple helices of various collagens, in a rather folded con-
formation [148–150]. Unlike GRP94, HSP47 does not require ATP and
may dissociate from collagens in a pH-dependent manner [148],
though it is not clear how this would be regulated in vivo. Ablation
of the mouse gene for HSP47 leads to embryonic lethality at E11.5, ac-
companied by defective collagen biosynthesis [151], which is needed
for mesenchymal tissues. These and other data are consistent with
HSP47 being a collagen-speciﬁc chaperone.
5.3. The calnexin/calreticulin network
The ER has one unique type of chaperone—lectins that bind to
glycoproteins. Two such chaperones are known: the lumenal protein
calreticulin (Crt) and the membrane-spanning chaperone calnexin
(Cnx) [152]. Both prefer a glycoprotein whose glycan has a mono-
glucosylated intermediate, as a result of trimming after the initial gly-
cosylation [153–155], although they also display distinct sensitivities
to folding context of individual glycans [32,156–158]. There is also
evidence that calnexin and calreticulin recognize features of proteins
other than glycans. Dissecting intermediates in hemagglutinin, Hebert
et al. observed that in contrast to Cnx, Crt bound primarily to early fold-
ing intermediates. Though the two chaperones share the same carbohy-
drate speciﬁcity, Crt binding depends on the oligosaccharides in the
more rapidly folding top domain of HA, whereas calnexin is less dis-
criminating [32]. Distinct epitopes also trigger calnexin and calreticulin
binding in MHC class I heavy chains [159]. Another major difference
between Crt and Cnx is the topology of their clients. Calreticulin
selectively interacts with nascent luminal secretory proteins, such
as transferring; however, when calreticulin was made artiﬁcially
membrane-anchored, the spectrum of proteins it recognized became
remarkably similar to that observed with calnexin [156]. Conversely,
calnexin's binding to its membrane-spanning client hemagglutinin
was reduced when the latter was expressed as a soluble anchor-
free protein [32].
5.3.1. Recruitment into the cycle
Calnexin and calreticulin participate in the dynamic sorting of
immature proteins towards attainment of the native state vs.elimination by ERAD, in the so-called “calnexin/calreticulin cycle”.
The sorting process consists of series of decision and commitment
events. The ﬁrst commitment event in the cycle is represented by
the sequential action of oligosaccharyl-transferase complex (OST)
and glucosidases I and II, which generates a mono-glucosylated pro-
tein intermediate [153,156,159–163]. Because OST and glucosidase I
are localized to the translocon [164,165], the presence of a glycosyla-
tion site within N-terminal 50 residues ensures attachment of the gly-
can moiety early in the translocation process, thus directing the
nascent protein into the Cnx/Crt cycle [166]. If the ﬁrst glycosylation
site is more C-terminal, the nascent protein may associate with BiP
instead and proceed along a different chaperone-assisted folding
path. The decision between the two chaperone complexes appears
to be due to competition, since removing the glycosylation sites al-
lows the protein that is normally a Cnx/Crt substrate to be recognized
by BiP [166]. Cnx/Crt recruits into the complex disulﬁde isomerase
ERp57 [167–170], which facilitates formation of the disulﬁde bonds
in the immature glycoproteins.
5.3.2. Return to the cycle
Once the protein is released from the calnexin/calreticulin complex
and further glucose-trimmed by glucosidase II to a high-mannose inter-
mediate, it is subject to a second triage decision. If it is in a mature,
secretion-competent conformation, it is targeted to the ER exit sites
and proceeds to its destination. If, however, it is in a non-native con-
formation, it can be recognized by the folding sensor UDP-glucose:
glycoprotein glucosyl transferase (UGT1) which re-glucosylates the
high-mannose moiety, thus re-committing the incompletely folded
polypeptide to the calnexin/calreticulin cycle for another round [153].
What proportion of glycoproteins is recommitted to repeated engage-
ment with Cnx/Crt is unknown, and in three out of four cell types stud-
ied, UGT1 is quite sub-stoichiometric to both Cnx/Crt and glucosidase II
(Table 1).
In addition to UGT1, the high-mannose intermediate can be recog-
nized by α-mannosidase I, resulting in the trimming of the mannose
moiety [171–173]. This step increases the chances of the
polypeptide's exit from the Cnx/Crt cycle, but does not commit it to
exit. Further mannose trimming, for example by EDEM1 and EDEM3
[174,175], produces a protein that can no longer be re-glucosylated
by UGT1, thus essentially removing it from the further refolding
attempts, and instead committing it to the degradation process
[173,176]. The relatively slow kinetics of α-mannosidase I enzymatic
activity is thought to provide a timer [171] that allows for a certain
residence time in the refolding part of the Cnx/Crt cycle, thus elimi-
nating futile cycling of an intermediate that is unable to fold. Recogni-
tion of both—the trimmed mannose residues and the non-native
polypeptide conformation by ERAD lectins such as OS9 and XTP3-B,
is thought to be the ﬁnal signal for degradation [177].
5.3.3. Client recognition
While we have a good idea of the sequence of events and identi-
ties of proteins in the calnexin cycle, there is much to be understood
about both the recognition of the polypeptide by the different chaper-
ones involved, and the consequences of their binding for the confor-
mational maturation of the polypeptide. The ﬁrst triage step – the
attachment of the glycan to nascent protein emerging from the trans-
location channel – is unlikely to be driven by global conformational
information. Local conformation, on the other hand, could affect the
recognition of the glycosylation site by OST, since proline residues
are not present at position +1 following the Asn, and are very rare
in position +3 [178]. The binding by Cnx/Crt in vivo may be medi-
ated by the speciﬁc glycan conﬁguration, even though in vitro Cnx
is able to bind unfolded, unglycosylated proteins [158]. For example,
when glucose trimming is slowed down, the mature, folded forms of
HA protein can be found bound to calnexin [163], suggesting that
only the sugar residues were mediating the binding in this case. On
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shown to induce a prolonged association of a normally Cnx/Crt
substrate (p62 viral glycoprotein) with BiP [166]. Given that BiP
preferentially binds immature folding intermediates, selection into
Cnx/Crt cycle is not likely to be based on the folding state of the
polypeptide.
The conformational maturation of polypeptides released from
Cnx/Crt is accessed by UGT1. The structural basis for this triage step
is still not well understood. Different modes of recognition have
been reported for UGT1 in vitro, from near-native conformation of
chymotrypsin inhibitor-2 [179], to non-native conformations of sev-
eral proteins with exposed hydrophobic residues on the surface
[180], to small, local deviations from the native fold [181]. In plants,
inactivating mutation of UGT1 results in less stringent ER retention
of a biochemically active brassinosteroid receptor mutant harboring
localized structural distortion [182]. It is possible that the degree of
non-nativeness recognized by this folding sensor is dependent on,
or inﬂuenced by, other, perhaps protein-speciﬁc, structural or confor-
mational information. Clearly, a better characterization of the sub-
strate recognition by UGT1 will be necessary for understanding the
principles of triage of folding intermediates in the ER.
When the above triage mechanism is not sufﬁcient, for ex-
ample under ER stress conditions, an additional lectin-based mecha-
nism exists. The ER membrane protein malectin speciﬁcally binds
the Glc2Man9GlcNAc2 intermediate glycan, presumably formed dur-
ing the re-glucosylation process, through a novel carbohydrate-
binding site in its luminal domain [183]. Glycoprotein recognition
by malectin does not affect their entry to the Cnx/Crt chaperone sys-
tem and malectin binds after Cnx [184]. Malectin is induced by ER
stress and associates preferentially with malfolded conformers of
glycoproteins, which is consistent with a role as a backup to the lectin
chaperone system that would be activated when misfolded forms
accumulate in the ER [184].
5.3.4. Functional consequences of lectin chaperone binding
What is the contribution of Cnx/Crt binding to the folding of their
substrates? One straightforward explanation, common to all chaper-
ones interacting with early intermediates, is preventing aggregation
of immature proteins [185]. The charged nature of glycans may in
itself serve an anti-aggregation function. Second, Cnx/Crt binding
mediates the recruitment of ERp57, which monitors the proper disul-
ﬁde bond structure of the glycoprotein (reviewed in [186]).
Another possibility is that attachment of the glycan residue and
binding of the lectin chaperones anchor the surrounding amino acids
to the surface of the protein. In addition to reducing the conformational
freedom of peptide backbone around the glycosylation site, such an-
choringmay allow conformations where amino acids that are normally
buried in the core remain on the surface, without compromising the
protein stability. Examination of 506 glycoprotein crystals showed
enrichment for surface-exposed aromatic and hydrophobic residues in
close spatial proximity to the N-glycosylation sites [38]. Petrescu et al.
[187] propose that without attached glycans, these residues will seek
the hydrophobic core of the molecule, thus favoring a different confor-
mation. For example, among four used glycosylation sites of mouse
tyrosinase, two are dispensable and two are necessary for efﬁcient
folding/function. The dispensable sites are GDEN203FT and RTAN337FS
(see Table 2), while the two whose occupancy is important for folding
efﬁciency are VFYN86RT and IFMN371GT, with neighboring aromatic
side chains. In fact, other studies suggest that glycans at certain posi-
tions can directly protect hydrophobic residues. In recombinant
erythropoietin, the inner regions of highly branched glycans appear
to stabilize the mature protein conformation by clinging to the
hydrophobic protein surface areas [188], while in an unassembled
alpha subunit of human chorionic gonadotropin, a glycan residue di-
rectly shields the hydrophobic core region that is normally protected
by interaction with the beta subunit [189].5.3.5. Organismal roles of the chaperones of the calnexin/calreticulin
cycle
The fundamental role of monitoring the quality of glycoproteins
would predict that the calnexin/calreticulin cycle is essential, but per-
haps the overlapping speciﬁcity of calnexin and calreticulin would
render each one of them dispensable. This expectation is born out in
tissue culture cells [190] and, surprisingly, also in knock-out animals.
Two different Cnx−/−mouse models had normal embryonic develop-
ment, but exhibited defective postnatal growth and neurological
and behavioral deﬁcits, accompanied by myelination-related defects
[176,191]. On the other hand, although calreticulin−/− mice [192]
showed variably early embryonic lethality, with notable defects in
heart development and function and a failure to absorb the umbilical
hernia, they had no other gross morphological changes. At least in
part, the heart function defects could be attributed to the calcium-
buffering function of calreticulin rather than to its chaperone activity,
since Crt−/− embryos had inhibited bradykinin-induced Ca2+ release
by the InsP3-dependent pathway [192].
The restricted phenotypes and normal development of most tis-
sues in these knock-out animals suggest, despite the distinctions in
client recognition between Crt and Cnx, as discussed above, that for
the majority of clients, the lectin chaperone requirement for their
efﬁcient folding is relatively relaxed. Alternatively, there may be suf-
ﬁcient ability in the non-lectin chaperone machinery to support the
folding of many, but not all clients. The speciﬁc neurological pheno-
types, myelination defects, and heart defects in knock-out animals
suggest speciﬁc, non-redundant requirements for either calnexin or
calreticulin function. At present, we don't knowwhether this require-
ment reﬂects a heightened chaperone dependency of the secretory
proteome in the susceptible cells (for example the presence of
substrates that are highly dependent on calnexin or calreticulin,
or the absence of compensating chaperones), or perhaps an in-
creased sensitivity of these cells to protein misfolding (or decreased
calcium buffering) in the ER.
5.4. Protein disulﬁde and prolyl isomerases
In addition to chaperones, which do not directly alter the structure
of itinerant proteins in the ER, the lumen is rich with enzymes that
can change protein structure. Two of the important types of enzymes
are protein disulﬁde isomerases (PDI) and prolyl isomerases (PPI),
and each type is represented by multiple family members (Table 1).
As discussed above, the importance of dealing with the constraint of
an oxidizing luminal environment provides obvious roles to several
PDIs. However, what is the signiﬁcance of such a large number of
related proteins with thioredoxin domains? Do they have unique
properties, or are many of them redundant? Similarly, among the
PPIs, do all of them function as prolyl isomerases and do they have
distinct substrates and functions?
5.4.1. The ER PDIs
At last count, there are 21 ER proteins with one or more
thioredoxin-like domains, the deﬁning feature of the PDI family
[193]. Each thioredoxin domain is a platform for the CXXC active
site that mediates the electron transfer involved in forming disulﬁde
bonds (see chapter 6 and [42]). The PDIs are oxidoreductases, which
can oxidize, reduce or isomerase disulﬁdes, depending on the redox
potential. Some PDIs, like ERdj5, are reductases in vivo and some, like
ERp29, are catalytically inactive. In addition, PDIs are also involved in
other activities: the highly abundant PDIA1 is the β subunit of prolyl
4-hydroxylase [194] and ERp44 binds to IP3 receptor [195]. The most
abundant PDIs in a number of distinct cell types are the 60 kDa pro-
tein disulﬁde isomerase PDIA1 and two structurally-related proteins,
P5 and ERp57 (Table 1).
The relevance of these PDIs to the fate of secretory proteins has
been established using pulse-chase experiments in the presence or
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disulﬁde bonds in the absence of PDI or ERp57, but its trafﬁc to
the Golgi is delayed, consistent with the presence of non-native fold-
ing intermediates that may require a disulﬁde isomerization reac-
tion [196]. Yet, given the large number of ER PDIs, an important
question is to what extent are they functionally redundant.
Genetic insight into the redundancy question is provided by the
phenotypes of null alleles of the three PDIs in Caenorhabditis elegans:
two of them are not essential, but the third is non-redundant and is
required for prolyl 4-hydroxylase activity in collagen biosynthesis
[197]. Williams et al. used an RNAi knockdown approach to address
the same question in mammalian cells [196]. They showed that
some PDIs clearly have deﬁned tasks. PDIA1 depletion impacted oxi-
dative folding of each one of several well-characterized secretory
liver proteins. However, the phenotype was surprisingly modest,
suggesting that other PDIs can compensate for PDIA1 depletion, albeit
with lower efﬁcacy. In contrast, depletion of ERp72 or P5, either alone
or in combination with PDI or ERp57, had minimal impact on oxida-
tive folding [196]. The RNAi approach also showed that one PDI,
ERp57, also has broad speciﬁcity, but with a clear preference for
glycoproteins. This speciﬁcity is explained because ERp57 must be
physically associated with the calnexin cycle components to catalyze
isomerization reactions with most of its substrates [198]. Yet, while
for some glycoproteins, like inﬂuenza virus hemagglutinin, the action
of ERp57 is important for post-translational, later phases of oxidative
folding, for many other glycoproteins association with ERp72 could
replace ERp57 and maintain folding competence [199]. In perhaps
similar fashion, P5 is a co-factor associated with BiP and interacts
with (at least some) BiP substrates [200].
In a similar approach, Rajpal et al. [56] examined the effect of
PDIA1 knockdown in β cells and showed that with reduced PDI activ-
ity, oxidation of proinsulin is unimpaired and, in fact, enhanced. This
is accompanied by the improved proinsulin exit from the ER and in-
creased total insulin secretion, with no evidence of ER stress [56].
Thus, in this professional secretory cell, PDIA1 slows down folding.
If the calnexin cycle has evolved with a specialized oxidoreductase
to facilitate native disulﬁde formation in complex glycoproteins, the
process of ER-associated degradation involves one PDI with a unique
activity: ERdj5 acts as a reductase, not an oxidase, on misfolded pro-
teins and it is the only PDI with a J domain that enables it to bind to
BiP and thus couple the peptide binding activity to the reductase ac-
tivity in order to triage proteins for ERAD [116]. ERp72 has also
been shown to interact with mutant thyroglobulin [201] and to par-
ticipate with ERp29, ERp57 and PDIA1 in the unfolding of polyoma
virus proteins during viral infection [202]. This unfolding is initiated
by ERp29, a PDI-family member without oxidoreductase activity,
which coordinates ERp57 and PDIA1 to unfold the C-terminus of the
capsid protein [202]. A ﬁnal example of a unique role for a PDI is
pERp1, which is specialized for supporting antibody secretion by
plasma cells [203,204]. All these studies now enable the conclusion
that although there is redundancy in supporting disulﬁde bond for-
mation, a number of PDIs perform unique functions due to speciﬁc
protein interactions mediated by their non-thioredoxin domains.
5.4.2. The ER immunophilins
The immunophilins/PPIs family is characterized by peptidyl-prolyl
cis/trans isomerase activity (at least in vitro) and sensitivity to one or
more of the immunosuppressive compounds cyclosporine A (CsA),
FK506 and rapamycin. Of the three branches of the family, two are
represented in the ER—the cyclosporine A (CsA)-binding cyclophilin
B (CypB), and at least ﬁve FK506-binding proteins, FKBP13, FKBP19,
FKBP22, FKBP23, and FKBP65. All of these immunophilins can catalyze
isomerization of prolines, often a rate-limiting step in folding [205],
but their mode of substrate recognition, and indeed the importance
of their PPI activity in vivo is still poorly understood. Some of the ER
immunophilins are induced when misfolded proteins accumulate,and even associate with misfolded substrates [206]. Yet, there is little
detailed understanding for how the ER immunophilins participate in
folding in the secretory pathway. Transferrin biosynthesis is sensitive
to cyclosporine A [207], so since CypB is the main target of CsA in the
ER [208], this immunophilin is implicated as a folding catalyst. CypB
also accelerates the resolution of a kinetically trapped, on-pathway
intermediate in immunoglobulin heavy chain folding, explaining the
requirement for isomerization of Pro32 in cells [85].
Most of the data about the other immunophilins documents asso-
ciation and genetic necessity, but with relatively little mechanistic
understanding. The large FKBP65 associates with the extracellular
matrix proteins tropoelastin and collagen during its residence in the
ER [209]. FKBP19 associates with CD81 in osteoblasts, which interacts
with CD9 and a prostaglandin receptor regulator, and these associations
cumulatively result in expression of interferon-inducible genes [210].
No speciﬁc substrate proteins for FKBP13 have been documented.
Human mutations in the FKBP14 gene are a cause of a type of
Ehlers–Danlos syndrome (EDS) with progressive kyphoscoliosis,
myopathy, and hearing loss [211]. Consistent with this phenotype,
FKBP14-deﬁcient ﬁbroblasts exhibit altered assembly of the extracel-
lular matrix in culture [211]. Both humans and mice deﬁcient for
CypB have Osteogenesis imperfecta and other bone abnormalities
during development, as well as molecular defects in collagen bio-
synthesis [212,213]. Nonetheless, the null phenotypes of these
immunophilins do not exhibit growth, development, fertility, immu-
nity or other defects aside from bone and connective tissues, as
would have been inferred from cell biological and proteomic studies.
One would have expected, for example, a defect in humoral immu-
nity, given the interactors of FKBP19 and CypB [85,210,214]. Similarly,
FKBP13 knockout mice do not have an obvious phenotype that would
be consistent with effects on folding of clients (Argon, unpublished
data).
C. elegans, an important model genetic organism, has three secre-
tory pathway FKBPs, expressed in hypodermal cells [215]. Neither
one is an essential protein, but as a functional group, all three are es-
sential for normal nematode development, collagen biogenesis, and
the formation of an intact exoskeleton under adverse physiological
conditions [215]. Thus, the genetic evidence indicates extensive func-
tional redundancy among the ER immunophilins in relation to protein
biosynthesis.
While studies implicating immunophilins in folding of speciﬁc sub-
strates are few, there are studies about the association of immunophilins
with the ER folding machinery. One functional interaction is between
FKBP23 and BiP. The Neurospora FKBP23 homologue binds physically
to BiP, which enhances the chaperone activity of the FKBP [216].
Mouse FKBP23 also binds BiP [217]. This binding is Ca++-dependent,
can suppress the ATPase activity of BiP through the PPIase activity of
FKBP23 and is mediated by catalyzing the cis/trans isomerization of
Pro117 in the ATPase domain of BiP [218].
An intriguing recent ﬁnding has been that ER immunophilins in-
teract with six of the protein disulﬁde isomerases [214], suggesting
that PPIs and PDIs can modulate each other's enzymatic activity in
vivo, as demonstrated in some in vitro cases [219,220]. CypB, in par-
ticular, interacts with three PDIs (PDIA1, PDIA4 and PDIA6) as well
as with three major chaperone networks in the ER (BiP, Cnx/Crt and
GRP94). The interaction of CypB with the lectin chaperones is medi-
ated by their proline-rich P domain, through the same surface that
binds ERp57, and is not sensitive to cyclosporine A [221]. Therefore,
the protein interaction module is distinct from the enzymatic activity
of CypB [221]. While the dynamics of these interactions in vivo are yet
to be explored, a number of cells in fact contain a sufﬁcient copy num-
ber of CypB to accommodate all these interactions (Table 1).
Recently, a role for CypB has been reported in ERAD. Either phar-
macological inhibition of CypB with cyclosporine A, or its depletion
with siRNA inhibits the degradation of a subset of misfolded soluble
luminal proteins, those that contain cis proline residues [208]. CypB
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alytic activity likely enhances disposal from the ER by resolving local
structures that are retro-transclocated inefﬁciently. Functional roles
in vivo for the other PPIs are yet to be elucidated.
5.5. Coordination of chaperone actions
Though we present each of the major chaperone systems separately,
their various modes of recognition and activities are all needed, in paral-
lel or in sequence, to fold proteins. In addition to the aforementioned se-
quential interaction of BiP and GRP94 with some clients, there are also
other examples of coordinated chaperone action. Many of the folding
factors that process non-glycoproteins interact sufﬁciently frequently
to be isolated as a multi-chaperone complex from antibody-producing
cells [222]. Intermediates of apolipoprotein B-100 were associated with
GRP94, ERp72, BiP, calreticulin, and cyclophilin B [223]. Remarkably, as
judged by subcellular fractionation, this array of chaperones remains as-
sociated with apolipoprotein B-100 during subsequent processing in the
Golgi complex [223]. Presumably, the association of chaperones and
lectins and/or folding enzymes creates a task-speciﬁc functional complex
that works ad hoc to fold a particular client.
When a large glycoprotein like thyroglobulin is bound by BiP,
GRP94, calreticulin, ERp29 and others [67,224], the binding is not
necessarily simultaneous; different domains of thyroglobulin likely
require different chaperones [225], and the cycles of binding and
release may be temporally programmed [226]. Likewise, when a
disulﬁde-bonded glycoprotein is targeted to ERAD, it is released
from the lectin chaperones, and its disulﬁdes are reduced by ERdj5,
which uses its J domain to couple the activity to BiP [116], in prepara-
tion for escort by OS-9 to the SEL1L/Hrd1 retrotranslocon [116]. These
examples illustrate the dynamic nature of the chaperone networks,
which are transient, come together based on individual protein's
‘needs’, as well as on the stage of folding that is being chaperoned.
The dynamic association of chaperones, enzymes and their substrates
and clients is also evident by the use of live cell imaging of their
fusions with ﬂuorescent protein [227–229].
6. Conclusions
The folding machinery in the lumen of the ER has evolved to
accommodate the unique features of the ER environment as well as
common signatures of secretory proteins, such as disulﬁde bonds
and glycans. Thus, while some of the ER chaperones and enzymes
work in similar fashion to homologous cytosolic chaperones (e.g. BiP
and HSP70, FKBP13 and FKBP12), other components (lectin chaperones
and adaptors, PDIs) are unique to this folding compartment. Even
GRP94, which is structurally highly similar to the two cytosolic
HSP90s, has evolved a distinct mode of chaperone action. To recognize
a particular substrate, the various ER chaperone systems use distinct
structural features, and for the most part engage in cycles of binding
and release, during which distinct folding reactions are executed. The
dynamics is even more complicated, since different chaperones may
work on different domains of a given proteinmolecule, andmay collab-
orate with an isomerase or a glycosylation enzyme, as required ad hoc
by the substrate. The identity of the substrate dictates which chaperone
acts as a hub, that in turn forms transient complexes with one or more
other folding factors, in characteristic order.
A common biophysical role that the ER folding machinery fulﬁlls
is restriction of the folding options early on, at a time that many path-
ways can be followed. Perhaps the unifying mechanism for this action
is “pinning” a patch of residues to either the core or the surface as
a means of favoring a particular folding pathway (e.g. [230]).
However, the BiP and the lectin chaperone networks achieve this goal
by recognizing distinctly different structures (peptides vs. glycans).
The BiP network marks peptides that are destined to be shielded from
solvent, and thereby allowing other segments of the polypeptide tofold around these peptides. The attachment of glycans and the subse-
quent association with the lectin chaperone network overcomes the
thermodynamic tendency of nearby patches enriched in hydrophobic
and aromatic residues to avoid display on the protein surface, thus ini-
tiating particular folding pathways. The action of PDIs and PPIs obvious-
ly restricts folding options by introducing irreversible steps. The GRP94
networkmay also restrict conformational space, but in away that is cur-
rently not understood because the structural cues of GRP94 engage-
ment with folding intermediates are yet to be deciphered.
Despite the impressive progress of our knowledge, many ques-
tions are still not resolved, including some that are common to sever-
al chaperone systems. How is the ‘productive’ folding intermediate
distinguished from the ‘unproductive’ one? Are the rules intrinsic to
the intermediate states, or are they different for different chaper-
ones? When a substrate binds cyclically to a chaperone, how is the
number of repetitive interactions determined? If a substrate presents
several chaperone binding sites, when does its folding depend on just
one dominant site (e.g. one glycan), and when are multiple sites re-
quired? When does the abundance of limiting co-chaperones, like
GRP170, or sensors, like UGT1, become an impediment for efﬁcient
folding?
Future studies should also explain how unassembled subunits stay
occupied with the ER chaperone networks, rather than sent for degra-
dation. Our knowledge of substrate recognition by components like
OS-9, which participate in such triage decisions, is still incomplete
and it will be important to understand when and how such compo-
nents engage with the folding machinery, and when they are commit-
ted to the substrate disposal via ERAD or autophagy.
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